MedPath
HSA Approval

KETOTIFEN SYRUP 1 mg/5 ml

SIN08766P

KETOTIFEN SYRUP 1 mg/5 ml

KETOTIFEN SYRUP 1 mg/5 ml

July 3, 1996

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

R06AX17

ketotifen

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

HOVID BHD

Active Ingredients

KETOTIFEN FUMARATE EQV KETOTIFEN

1 mg/5 ml

Ketotifen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

KETOTIFEN SYRUP 1 mg/5 ml - HSA Approval | MedPath